Clinical Terminal
Cardiology

Topol, at AHA Sessions, Lists Underused Tools in Cardiovascular Care

Eric Topol, MD, founder and director of Scripps Translational Research Institute and professor of molecular medicine at Scripps Research, told attendees at the American Heart Association Scientific Sessions (Nov. 6-9, 2026, Chicago) that cardiologists are leaving a range of available tools unused. The remarks came in an opening session address, according to Healio; Topol received the AHA's James B. Herrick Award of Outstanding Achievement in Clinical Cardiology at the meeting. The source reports no study data, sample sizes or endpoints — the presentation was a list of practices Topol said are underused, not a trial.

By The Desk - Jordan Leahy Nov 9, 2026

Topol, at AHA Sessions, Lists Underused Tools in Cardiovascular Care

Among the items he cited were exercise prescriptions, referencing an American College of Cardiology scientific statement released in October; polygenic risk scores, which he said cost $20 to run via a single nucleotide polymorphism array while some companies charge $300; six-lead ECG and handheld ultrasound in routine exams; and information embedded in routine medical images, including chest X-rays, mammograms for breast artery calcification (which he said Maryland requires in mammography readouts) and retinal images. He also pointed to the FDA-approved fat attenuation index score (CaRi-Heart, Caristo Diagnostics) for quantifying coronary inflammation.

Topol disclosed serving on scientific advisory boards for Abridge, Aevius, Danaher, Microsoft and Mercor.

Why it matters: The talk points to workflow and reimbursement questions — Topol recounted colleagues citing lack of reimbursement for handheld ultrasound — that heart programs would face in adopting the practices he described.